Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial

BACKGROUND: Carbapenem antibiotics are considered the treatment of choice for serious extended-spectrum beta-lactamase (ESBL)-producing Gram-negative bacteria (GNB) infections. The study objectives were to evaluate efficacy and safety of de-escalation therapy to ertapenem for treatment of infections...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Infect Dis
Autors principals: Rattanaumpawan, Pinyo, Werarak, Peerawong, Jitmuang, Anupop, Kiratisin, Pattarachai, Thamlikitkul, Visanu
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5333449/
https://ncbi.nlm.nih.gov/pubmed/28249572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2284-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars